Asian Biomed
HighLight Image

Anticipating a new deadly epidemic

The emergence of new highly pathogenic infectious diseases (HPID) in less developed parts of the world have presented major challenges to authorities, particularly in areas with limited economic and medical resources. There is usually significant delay in the appropriate response to such an epidemic, resulting in loss of life and further dissemination. Lancet published a statement by the European Network of Infectious Diseases Commission regarding best responses to such outbreaks. It represents a concise summary of what ideally needs to be done. However, most of the concepts are not immediately applicable in a poor country with very limited institutional structures, trained personnel, and financial resources. Geographic, cultural, educational, and climatic conditions often have great impact on the quality of the response to a deadly epidemic. The situation is even more critical if the responsible agent is not readily identified.

Read more...
Editor Choices
HighLight Image
The urge to purge: colonic ‘hydrotherapy’, unproven but widely practiced, potentially dangerous, and unsupported by scientific evidence
Read more...
HighLight Image
Relationship between the 308GA polymorphism of the tumor necrosis factor alpha gene and acute or chronic pancreatitis: a meta-analysis
Read more...
HighLight Image
Establishment and characterization of urine-resistance cell sub-strain of human bladder cancer
Read more...
HighLight Image
Human growth hormone gene expression in vitro following rAAV2/1-mediated gene transfer
Read more...
HighLight Image

Anticipating a new deadly epidemic


Read more...
Aims and Scope

Asian Biomedicine (Research, Reviews and News) is an international journal devoted to peer-reviewed contributions dealing with biomedical sciences from experimental to clinical aspects. The Journal publishes review articles, original articles, technical and clinical reports bimonthly. Reviews of various topics of relevance to Asia will be solicited. Innovative experimental studies and behavioral or epidemiological aspects of medicine will be addressed. We are also soliciting manuscripts dealing with Asian medical history and ethics.




FAQ

Where is the "Asian Biomedicine" indexed?
"Asian Biomedicine" is currently indexed by Science Citation Index Expanded (SciSearch), Journal Citation Index/Science Edition, Scopus and Chemical Abstracts.

What is the current Impact Factor?
"Asian Biomedicine" has been indexed in the Thompson ISI database since the first publication in 2007. The current Imfact Factor is 0.256 in 2011.

How many copies of " Asian Biomedicine" are in circulation per issue?
Each issue is sent to approximately 1,500 regular members and medical libraries throughout the world under international cooperation with IOS Press (Amsterdam).

How often is the "Asian Biomedicine" published?
"Asian Biomedicine" is published bimonthly (February, April, June, August, October and December).
All articles of each issue will be released on the website before the publication in print.

Read more...